For Diginex, a $1.5 Billion All-Stock Deal and a Sub?$1 Stock Create an Unprecedented Squeeze

Diginex has until June 30 to close $1.5B Resulticks deal; stock at $0.90 endangers Nasdaq listing, but ESG tailwinds offer long-term potential.

The clock is running out on Diginex’s most ambitious bet yet. The London-based RegTech firm has until June 30 to close its all-stock acquisition of AI specialist Resulticks — a transaction valued at $1.5 billion. Yet the company’s own shares are trading at $0.90, well below the $1.32 price the deal was originally priced against. That gap is testing investor patience and putting the company’s Nasdaq listing at risk.

Diginex operates in a market with undeniable structural tailwinds. The global ESG-compliance software market is projected to expand from $1.3 billion in 2026 to nearly $2.9 billion by 2031, a compound annual growth rate of 17.4%. The push comes not from fashion but from binding regulation: the EU’s Green Claims directive, ISSB sustainability standards, and the Digital Product Passport all take effect in 2026 and 2027. Diginex has positioned itself squarely in that space with a unified platform covering carbon accounting, sustainability reporting, human rights due diligence, and supply-chain transparency. The company recently abandoned its former holding structure and merged its separate ESG units into a single operational framework.

Complicating matters, Nasdaq compliance remains a serious headache. On March 23, Diginex received a notice from the exchange’s listings department after its closing price stayed below $1 for 30 consecutive trading days, violating Rule 5550(a)(2). The company has until September 21 to regain compliance — meaning at least ten consecutive trading sessions above the $1 threshold. A reverse stock split in April failed to produce a durable fix. The stock’s relative strength index now sits at 32.5, flirting with oversold territory, while annualized volatility runs at roughly 123%.

The Resulticks deal is seen as the most powerful lever to pull Diginex out of its current bind. The target company develops AI-driven customer software and generated around $150 million in revenue last year, with operating profit of roughly $50 million. Diginex is paying entirely in equity, so the effective price depends on its own share price — a variable that has moved sharply against the company. Investors increasingly doubt the deal will close on time. The extension to June 30 did little to calm nerves; the stock lost 3.35% on Tuesday and has fallen nearly 7% over the past week.

Beyond the immediate deadline, Diginex has been quietly building scale through acquisitions worth over $100 million since its Nasdaq listing — including Matter DK ApS, The Remedy Project, and Plan A. The company recently launched “Risk-to-Remedy”, a supply-chain due diligence tool that combines its LUMEN risk-assessment platform with APPRISE for direct worker engagement, producing regulatory-grade reports within a single framework. These moves map to a clear strategic shift: from a holding company of separate ESG businesses to an integrated technology platform powered by AI.

For Diginex, the stakes could hardly be more asymmetric. A successful Resulticks close would inject a profitable AI engine and potentially lift the stock above the $1 Nasdaq threshold. Failure would not only unravel the acquisition but also cast doubt on the broader platform strategy — and leave the company scrambling to meet its September compliance deadline with no obvious catalyst in sight. The market is watching every tick.